Synthesis and anticancer evaluation of new lipophilic 1,2,4 and 1,3,4-oxadiazoles

European Journal of Medicinal Chemistry
2019.0

Abstract

A series of1,2,4- and 1,3,4-oxadiazole derivatives were synthesized and evaluated for their anticancer activity. Halogenated 1,2,4-oxadiazoles were obtained from benzonitrile and coupled either lipophilic amines or with aminoalcohols. Lipophilic 1,3,4-oxadiazole derivatives were obtained through the Mannich reactions between 5-(aryl)-1,3,4-oxadiazole-2-thiol and alkylated or acylated amines. The in vitro cytotoxic effects were evaluated against 4T1- mammary carcinoma and CT26 - colon cancer cells. The best results were obtained for the 1,3,4-oxadiazole coupled to alkylated piperazine with 10-14 carbon chain moiety, with IC<sub>50</sub> values ranging from 1.6 to 3.55μΜ for the 4T1 cell line, and from 1.6 to 3.9 μM for the CT26.WT cell line, and selectivity index up to 19. The most potent compounds were investigated with AnnexinV and PI staining as indicative of apoptosis induction.

Knowledge Graph

Similar Paper

Synthesis and anticancer evaluation of new lipophilic 1,2,4 and 1,3,4-oxadiazoles
European Journal of Medicinal Chemistry 2019.0
Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles
European Journal of Medicinal Chemistry 2012.0
Synthesis of some novel 3,5-disubstituted 1,3,4-oxadiazole derivatives and anticancer activity on EAC animal model
Medicinal Chemistry Research 2011.0
Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents
European Journal of Medicinal Chemistry 2012.0
Design, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents
European Journal of Medicinal Chemistry 2019.0
Synthesis and antitumor evaluation of some 1,3,4-oxadiazole-2(3H)-thione and 1,2,4-triazole-5(1H)-thione derivatives
Medicinal Chemistry Research 2012.0
One-pot, four-component synthesis of novel cytotoxic agents 1-(5-aryl-1,3,4-oxadiazol-2-yl)-1-(1H-pyrrol-2-yl)methanamines
European Journal of Medicinal Chemistry 2014.0
Synthesis and antitumor activities of novel hybrid molecules containing 1,3,4-oxadiazole and 1,3,4-thiadiazole bearing Schiff base moiety
Bioorganic &amp; Medicinal Chemistry Letters 2014.0
Novel 1,3,4-heterodiazole analogues: Synthesis and in-vitro antitumor activity
European Journal of Medicinal Chemistry 2012.0
Synthesis, molecular docking study, and anticancer activity of triaryl-1,2,4-oxadiazole
Medicinal Chemistry Research 2013.0